Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,793.20
(
-1.41%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
106.58
(
5.89%
)
Bitcoin
71,143.35
(
-3.79%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 110882

Tuesday, 12/14/2010 7:00:27 PM

Tuesday, December 14, 2010 7:00:27 PM

Post# of 257257

VRUS starts phase-2 trial of PSI-7977 + ribavirin w/o interferon in genotype-2/3:

I realize VRUS already diluted not so long ago at $29/share but, given the continued run-up to almost $50 now, I think they'd be wise to do another offering. I put EXEL in the same camp (especially given that EXEL has a very poor balance sheet).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now